4//SEC Filing
Golembiewski Michael Joseph 4
Accession 0001104659-23-027915
CIK 0001017491other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:06 PM ET
Size
5.0 KB
Accession
0001104659-23-027915
Insider Transaction Report
Form 4
Golembiewski Michael Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2023-02-28$0.67/sh+12,500$8,400→ 90,987 total
Footnotes (1)
- [F1]These shares were acquired under the Company's 2020 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
SEELOS THERAPEUTICS, INC.
CIK 0001017491
Entity typeother
Related Parties
1- filerCIK 0001639479
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:06 PM ET
- Size
- 5.0 KB